Is Medpace Holdings Stock a Good Investment?
Medpace Holdings Investment Advice | MEDP |
- Examine Medpace Holdings' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Medpace Holdings' leadership team and their track record. Good management can help Medpace Holdings navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Life Sciences Tools & Services space and any emerging trends that could impact Medpace Holdings' business and its evolving consumer preferences.
- Compare Medpace Holdings' performance and market position to its competitors. Analyze how Medpace Holdings is positioned in terms of product offerings, innovation, and market share.
- Check if Medpace Holdings pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Medpace Holdings' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Medpace Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Medpace Holdings is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Medpace Holdings Stock
Researching Medpace Holdings' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 19.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.77. Medpace Holdings recorded earning per share (EPS) of 12.64. The entity had not issued any dividends in recent years.
To determine if Medpace Holdings is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Medpace Holdings' research are outlined below:
| Medpace Holdings generated a negative expected return over the last 90 days | |
| Medpace Holdings is unlikely to experience financial distress in the next 2 years | |
| Medpace Holdings currently holds 126.23 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Medpace Holdings has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Medpace Holdings' use of debt, we should always consider it together with its cash and equity. | |
| Medpace Holdings has a strong financial position based on the latest SEC filings | |
| Over 87.0% of Medpace Holdings shares are owned by institutional investors | |
| Latest headline from news.google.com: Drug Development Inputs Services Stocks Q4 In Review Medpace Vs Peers - Yahoo Finance |
Medpace Holdings Quarterly Liabilities And Stockholders Equity |
|
Medpace Holdings uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Medpace Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medpace Holdings' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 22nd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Medpace Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Medpace Holdings' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-10-30 | 2017-09-30 | 0.36 | 0.4 | 0.04 | 11 | ||
2016-11-03 | 2016-09-30 | 0.34 | 0.4 | 0.06 | 17 | ||
2017-07-31 | 2017-06-30 | 0.3 | 0.38 | 0.08 | 26 | ||
2019-02-25 | 2018-12-31 | 0.67 | 0.76 | 0.09 | 13 | ||
2020-02-24 | 2019-12-31 | 0.75 | 0.85 | 0.1 | 13 | ||
2018-04-30 | 2018-03-31 | 0.44 | 0.55 | 0.11 | 25 | ||
2016-08-16 | 2016-06-30 | 0.34 | 0.45 | 0.11 | 32 | ||
2021-04-26 | 2021-03-31 | 1 | 1.14 | 0.14 | 14 |
Medpace Holdings Target Price Consensus
Medpace target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Medpace Holdings' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 11 | Buy |
Most Medpace analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Medpace stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Medpace Holdings, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMedpace Holdings Target Price Projection
Medpace Holdings' current and average target prices are 324.23 and 347.92, respectively. The current price of Medpace Holdings is the price at which Medpace Holdings is currently trading. On the other hand, Medpace Holdings' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Medpace Holdings Market Quote on 23rd of March 2025
Target Price
Analyst Consensus On Medpace Holdings Target Price
Medpace Holdings Analyst Ratings
Medpace Holdings' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Medpace Holdings stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Medpace Holdings' financials, market performance, and future outlook by experienced professionals. Medpace Holdings' historical ratings below, therefore, can serve as a valuable tool for investors.Know Medpace Holdings' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Medpace Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medpace Holdings backward and forwards among themselves. Medpace Holdings' institutional investor refers to the entity that pools money to purchase Medpace Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Td Asset Management Inc | 2024-12-31 | 464 K | Goldman Sachs Group Inc | 2024-12-31 | 441.2 K | Capital World Investors | 2024-12-31 | 438.4 K | Td Global Investment Solutions – Td Epoch | 2024-12-31 | 438.1 K | Clearbridge Advisors, Llc | 2024-12-31 | 409.7 K | American Capital Management Inc | 2024-12-31 | 329.4 K | Gw&k Investment Management, Llc | 2024-12-31 | 275.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 267.9 K | Spyglass Capital Management Llc | 2024-12-31 | 262.7 K | Blackrock Inc | 2024-12-31 | 2.7 M | Vanguard Group Inc | 2024-12-31 | 2.6 M |
Medpace Holdings' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.88 B.Market Cap |
|
Medpace Holdings' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.29 | 0.30 | |
| Return On Capital Employed | 0.45 | 0.47 | |
| Return On Assets | 0.19 | 0.20 | |
| Return On Equity | 0.49 | 0.51 |
Determining Medpace Holdings' profitability involves analyzing its financial statements and using various financial metrics to determine if Medpace Holdings is a good buy. For example, gross profit margin measures Medpace Holdings' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Medpace Holdings' profitability and make more informed investment decisions.
Evaluate Medpace Holdings' management efficiency
Medpace Holdings has return on total asset (ROA) of 0.1486 % which means that it generated a profit of $0.1486 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5842 %, meaning that it created $0.5842 on every $100 dollars invested by stockholders. Medpace Holdings' management efficiency ratios could be used to measure how well Medpace Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/23/2025, Return On Tangible Assets is likely to grow to 0.30. Also, Return On Capital Employed is likely to grow to 0.47. At this time, Medpace Holdings' Total Current Liabilities is relatively stable compared to the past year. As of 03/23/2025, Non Current Liabilities Total is likely to grow to about 178 M, while Liabilities And Stockholders Equity is likely to drop slightly above 1.4 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 26.67 | 14.32 | |
| Tangible Book Value Per Share | 4.16 | 4.37 | |
| Enterprise Value Over EBITDA | 21.80 | 15.90 | |
| Price Book Value Ratio | 12.46 | 13.08 | |
| Enterprise Value Multiple | 21.80 | 15.90 | |
| Price Fair Value | 12.46 | 13.08 | |
| Enterprise Value | 6.3 B | 4.2 B |
Management at Medpace Holdings focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Beta 1.471 |
Basic technical analysis of Medpace Stock
As of the 23rd of March, Medpace Holdings secures the Mean Deviation of 1.47, risk adjusted performance of (0.03), and Standard Deviation of 2.0. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medpace Holdings, as well as the relationship between them.Medpace Holdings' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medpace Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medpace Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medpace Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Medpace Holdings' Outstanding Corporate Bonds
Medpace Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medpace Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medpace bonds can be classified according to their maturity, which is the date when Medpace Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US58506YAS19 Corp BondUS58506YAS19 | View | |
| MEDTRONIC INC 4375 Corp BondUS585055BT26 | View | |
| MEDTRONIC INC 4625 Corp BondUS585055BU98 | View | |
| US58502BAE65 Corp BondUS58502BAE65 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Medpace Holdings' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Medpace Holdings' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 1.47 | |||
| Coefficient Of Variation | (2,561) | |||
| Standard Deviation | 2.0 | |||
| Variance | 3.99 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | 0.0637 | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 10.53 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 2.24 | |||
| Skewness | (1.46) | |||
| Kurtosis | 2.92 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 1.47 | |||
| Coefficient Of Variation | (2,561) | |||
| Standard Deviation | 2.0 | |||
| Variance | 3.99 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | 0.0637 | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 10.53 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 2.24 | |||
| Skewness | (1.46) | |||
| Kurtosis | 2.92 |
Consider Medpace Holdings' intraday indicators
Medpace Holdings intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medpace Holdings stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medpace Holdings Corporate Filings
| 11th of March 2025 Other Reports | ViewVerify | |
F4 | 10th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 24th of February 2025 Other Reports | ViewVerify | |
10K | 11th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
Medpace Stock media impact
Far too much social signal, news, headlines, and media speculation about Medpace Holdings that are available to investors today. That information is available publicly through Medpace media outlets and privately through word of mouth or via Medpace internal channels. However, regardless of the origin, that massive amount of Medpace data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Medpace Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Medpace Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Medpace Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Medpace Holdings alpha.
Medpace Holdings Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Medpace Holdings can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Medpace Holdings Historical Investor Sentiment
Investor biases related to Medpace Holdings' public news can be used to forecast risks associated with an investment in Medpace. The trend in average sentiment can be used to explain how an investor holding Medpace can time the market purely based on public headlines and social activities around Medpace Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Medpace Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Medpace Holdings and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Medpace Holdings news discussions. The higher the estimate score, the more favorable the investor's outlook on Medpace Holdings.
Medpace Holdings Maximum Pain Price Across June 20th 2025 Option Contracts
Medpace Holdings' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Medpace Holdings close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Medpace Holdings' options.
Medpace Holdings Corporate Management
| Kevin Brady | CFO Treasurer | Profile | |
| Brandon Ebken | Chief Officer | Profile | |
| Gina MPH | Senior Monitoring | Profile | |
| August MD | Chairman CEO | Profile | |
| Stephen JD | General Officer | Profile | |
| Stephen Ewald | General Counsel, Corporate Secretary | Profile |
Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.